Pheon Therapeutics

Last updated: August 28, 2025
CEO Bertrand Damour
CEO Bertrand Damour
Country: UK | Funding: $188M (+)

Website: https://pheontx.com

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

Competitors